Next Article in Journal
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
Previous Article in Journal
Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 15
Issue 12
10.3390/cancers15123091
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2021, 13(16), 4198.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198

by
Gwen Schroyen
1,2,3,*,
Jeroen Blommaert
1,2,4,
Donatienne van Weehaeghe
5,6,
Charlotte Sleurs
1,2,4,
Mathieu Vandenbulcke
1,7,8,
Nina Dedoncker
1,7,
Sigrid Hatse
2,4,
An Goris
1,7,
Michel Koole
2,5,
Ann Smeets
2,4,9,
Koen van Laere
1,3,5,6,
Stefan Sunaert
1,3,10,† and
Sabine Deprez
1,2,3,†
1
Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium
2
Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium
3
Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium
4
Department of Oncology, KU Leuven, 3000 Leuven, Belgium
5
Department of Nuclear Medicine and Molecular Imaging, KU Leuven, 3000 Leuven, Belgium
6
Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, 3000 Leuven, Belgium
7
Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium
8
Psychiatry, University Hospitals Leuven, 3000 Leuven, Belgium
9
Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium
10
Radiology, University Hospitals Leuven, 3000 Leuven, Belgium
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2023, 15(12), 3091; https://doi.org/10.3390/cancers15123091
Submission received: 12 April 2023 / Accepted: 10 May 2023 / Published: 7 June 2023
Browse Figure
Versions Notes
In the original publication [1], there was a mistake in Figure 2A as published. The upper panel was incorrectly a duplicate version of the lower panel, and included PVC VT values, instead of uncorrected VT values. In the caption, a typo in referring to legend colors (blue instead of red image color) was also observed. The corrected Figure 2 appears below. The accompanying text in the manuscript does not include these mistakes and therefore remains unchanged. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Schroyen, G.; Blommaert, J.; van Weehaeghe, D.; Sleurs, C.; Vandenbulcke, M.; Dedoncker, N.; Hatse, S.; Goris, A.; Koole, M.; Smeets, A.; et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198. [Google Scholar] [CrossRef] [PubMed]
Cancers 15 03091 g001 550
Figure 2. Regions showing [18F]DPA714 VT-ratio differences with LGA. Fifteen chemotherapy-treated patients (C+) were assessed for [18F]DPA714 VT-ratio and compared to 15 chemotherapy-naïve patients (C−) and 15 healthy women (HC). (A) Volumes-of-interest based logan-graphical analysis (LGA) results of 11 volumes of interest are presented, showing higher VT-ratio in C+ patients compared to HC in the parietal lobe. After partial volume correction (PVC), C+ patients showed higher VT-ratio compared to C− and HC in the parietal and occipital lobe and additionally in the frontal lobe when compared to HC (* p < 0.05). (B) Voxel-based whole brain LGA results are presented, showing higher VT-ratio in C+ patients compared to HC (red) and C− patients (orange) in the occipital and parietal lobe. After PVC, only differences between C+ and HC persisted for VT-ratio images (all puncorrected < 0.005, pcluster FWE-corrected < 0.05). Section numbers refer to Montreal Neurological Institute coordinates. Abbreviations: HP = hippocampus, VT = total distribution volume, WM = white matter.
Figure 2. Regions showing [18F]DPA714 VT-ratio differences with LGA. Fifteen chemotherapy-treated patients (C+) were assessed for [18F]DPA714 VT-ratio and compared to 15 chemotherapy-naïve patients (C−) and 15 healthy women (HC). (A) Volumes-of-interest based logan-graphical analysis (LGA) results of 11 volumes of interest are presented, showing higher VT-ratio in C+ patients compared to HC in the parietal lobe. After partial volume correction (PVC), C+ patients showed higher VT-ratio compared to C− and HC in the parietal and occipital lobe and additionally in the frontal lobe when compared to HC (* p < 0.05). (B) Voxel-based whole brain LGA results are presented, showing higher VT-ratio in C+ patients compared to HC (red) and C− patients (orange) in the occipital and parietal lobe. After PVC, only differences between C+ and HC persisted for VT-ratio images (all puncorrected < 0.005, pcluster FWE-corrected < 0.05). Section numbers refer to Montreal Neurological Institute coordinates. Abbreviations: HP = hippocampus, VT = total distribution volume, WM = white matter.
Cancers 15 03091 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Schroyen, G.; Blommaert, J.; van Weehaeghe, D.; Sleurs, C.; Vandenbulcke, M.; Dedoncker, N.; Hatse, S.; Goris, A.; Koole, M.; Smeets, A.; et al. Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198. Cancers 2023, 15, 3091. https://doi.org/10.3390/cancers15123091

AMA Style

Schroyen G, Blommaert J, van Weehaeghe D, Sleurs C, Vandenbulcke M, Dedoncker N, Hatse S, Goris A, Koole M, Smeets A, et al. Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198. Cancers. 2023; 15(12):3091. https://doi.org/10.3390/cancers15123091

Chicago/Turabian Style

Schroyen, Gwen, Jeroen Blommaert, Donatienne van Weehaeghe, Charlotte Sleurs, Mathieu Vandenbulcke, Nina Dedoncker, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, and et al. 2023. "Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198" Cancers 15, no. 12: 3091. https://doi.org/10.3390/cancers15123091

APA Style

Schroyen, G., Blommaert, J., van Weehaeghe, D., Sleurs, C., Vandenbulcke, M., Dedoncker, N., Hatse, S., Goris, A., Koole, M., Smeets, A., van Laere, K., Sunaert, S., & Deprez, S. (2023). Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198. Cancers, 15(12), 3091. https://doi.org/10.3390/cancers15123091

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop